OBJECTIVES: Long-term antiplatelet therapy is typically considered standard of care for secondary prevention of cardiac events. The goal of this study was to examine patterns of use and total health care utilization in patients receiving clopidogrel.
PCV24 7309 HEALTH CARE RESOURCE UTILIZATION BY PATIENTS WITH ESSENTIAL HYPERTENSION
Nair RR, Bollu VK, Blake SG The University of Louisiana at Monroe, Monroe, LA, USA OBJECTIVE: About 30% of US adult population suffers from hypertension and this rate is expected to increase in coming years. This study examined current therapeutic choices associated with treatment of essential hypertension. Hypertensive related and total health care resource utilization were also examined. METHODS: Data from 2000 Medical Expenditure Panel Survey were retrospectively analyzed. Patients were identified by the ICD-9 CM code "401", who were above 17 years of age and were not pregnant. All patients who received an anti-hypertensive also had a diagnosis of essential hypertension. Health care resource utilization was measured from ER, inpatient, physician, and prescription medicine expenses. RESULTS: A total of 2894 patients were identified as diagnosed with essential hypertension. Patients in the study group were predominantly female (58%), caucasians (78%), and over 50 years of age (75%). Angiotensin Converting Enzyme inhibitors (ACE) and Calcium Channel Blockers (CCB) formed the major treatment choices for essential hypertension. The choice of treatment strategy differed with patient's type of insurance. Only 25% of study group rated their general health as excellent or very good . About 8% of the study population had at least one episode of stroke. Total health care expenses for the study group exceeded $15 million. The mean total health care expense for a single hypertensive patient was above $5000. Prescription anti-hypertensives were 23% of the total health care expenses. Physician and ER visits were found to be the major cost categories for the hypertension patients. CONCLUSIONS: Health care resource utilization by hypertensive patients is expected to increase with the increase in the number of patients. CCBs and ACE inhibitors formed the treatment of choice for hypertension treatment. Prescription medicine expenses formed only a small percentage of the total health care expense.
PCV25 TOBACCO COST-EFFECTIVENESS ANALYSES AND THE PAYER: IS THE SHORT TERM LONG OVERDUE?
Reed KE, Wieck SG, Tengs TO Milliman USA, Denver, CO, USA OBJECTIVE: Despite overwhelming evidence that tobacco cessation interventions are cost-effective, only 24% of employersponsored health plans offer any coverage for tobacco-use treatment. One reason may be that health plans fear that they won't recoup projected savings because of member turnover, which averages 10-20% annually. The objective of this study was to assess whether the cost-effectiveness literature provides health plans with the information they need to make tobacco treatment coverage decisions. METHODS: We performed a comprehensive search for all cost-effectiveness analyses of tobacco cessation interventions published in 1980 or later. Two readers independently reviewed 23 analyses and recorded several items including: 1) the perspective of the analysis; 2) whether medical cost savings were assessed; 3) the time-frame over which the medical costs were calculated; and 4) whether comprehensive program implementation costs were included. RESULTS: Of the 23 analyses reviewed, 13 described the cost-effectiveness of potentially reimbursable services or medications from the payer's perspective. However, of the 13, only two incorporated medical cost offsets from smoking cessation. Neither described the cost implications over the short term nor did they include the program costs that are of interest to payers. CONCLUSIONS: Published cost-effectiveness information for tobacco treatments is not presented in a way that is useful to health plans. Providing information in a manner more useful to managed care organizations, emphasizing short term cost savings, could lead to better coverage of tobacco treatment.
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MEDICARE EXPENDITURES IN RELATION TO FUNCTIONAL HEALTH STATUS POST-STROKE FOR A NATIONALLY-REPRESENTATIVE SAMPLE OF MEDICARE BENEFICIARIES FROM 1996 TO 2000
Singhal PK, Stuart B, Menis M, Kamal-Bahl S University of Maryland, Baltimore, MD, USA OBJECTIVES: 1) Using Medicare Current Beneficiary Survey (MCBS) develop a retrospective cohort of Medicare beneficiaries with incident stroke; and 2) determine Medicare expenditures in relation to health status and time since stroke. METHODS: We used longitudinal MCBS surveys linked to Medicare claims from 1996 to 2000. The MCBS reports data from in-home interviews on a nationally-representative sample of approximately 17,000 Medicare beneficiaries each year. It contains detailed information on beneficiaries' socio-demographic characteristics and general
